New York bills · 2025 Regular Session
New York S 2383
Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Mario Mattera (Republican/Conservative)
Summary
Official abstract published by the New York legislature
Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · Senate
REFERRED TO HEALTH - Jan 16, 2025 · Senate
REFERRED TO HEALTH